On the other hand, we provided a druggable protein, ADIPOQ, for drug discovery and drug design for diabetic cures with dyslipidemia that might be interesting for pharmaceutical insight and drug design-based natural products. The gene discussed is ADIPOQ; the disease is metabolic syndrome.